Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation?
Menu piccolo
Institute
About us
Documents
News
Organization chart
Locations
Staff
Contact us
Activities
Education
Career opportunities
Meetings
PNRR
Research
Research Areas
Biomolecules
Imaging
e-Health
Projects
Publications
Patents
Resources
Awards and acknowledgments
Statistics
Private Area
Login
Link utili
Staff
Research areas
Activities
Bibliography
Papers
CMS
Generic
IT
Basic info
Abstract
Related activities
Related bibliography
Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation?
(
335 views
)
D'Antuono F, Gallicchio R, Venetucci A,
Nardelli A
, Giacomobono S, Pellegrino T, Tempone A, Di Leo A, Gattozzi D,
Storto G
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2013 Oct;
40: N/D-N/D.
Export to BibTeX
Export to EndNote
Paper type:
Journal Article, Abstract, Conference,
Impact factor:
5.217,
5-year impact factor:
4.728
Url:
Not available.
Keywords:
Not available.
Affiliations:
*** IBB - CNR ***
References:
Not available.
Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation?
Not available.
Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation?
No results.
Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation?
Filter those results▼
Query: [
X
]
Options:
Any
All
Exact
Extended
IBB affiliation
OR
AND
Authors: [
X
]
Paper type: [
X
]
Start date: [
X
]
End date: [
X
]
Site:
All sites
Naples - De Amicis
Naples - Castellino
Turin
Staff
Research areas
Activities
Bibliography
Papers
CMS
Generic
[
Clear form
]
Select the year:
Default
ALL YEARS
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
<=2001
Other filter:
([btitle,keywords] "differentiated" OR [ ...
Search related bibliography on PubMed
End of page
Copy&Paste Friendly
Export all to BibTeX
Export all to EndNote
Sort by: date
▼
▲
title
▲
▼
journal
▲
▼
authors
▲
▼
I.F.
▲
▼
Russo M, Malandrino P, Moleti M, Vermiglio F, D'Angelo A, La Rosa G, Sapuppo G, Calaciura F, Regalbuto C, Belfiore A, Vigneri R, Pellegriti G
*
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors
(
380 views
)
Pediatr Blood Cancer (ISSN: 1545-5009linking)
,
2018 Sep;
65(9): e27226-e27226.
Impact Factor:
2.513
View
Export to BibTeX
Export to EndNote
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A,
Cuocolo A
, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R
*
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience
(
557 views
)
Endocrine (ISSN: 1355-008x, 1355-008xlinking)
,
2017 Nov 06;
59(1): 90-101.
Impact Factor:
3.179
View
Export to BibTeX
Export to EndNote
Salvatore B
, Klain M, Nicolai E, D'Amico D, De Matteis G, Raddi M,
Fonti R
, Pellegrino T,
Storto G
,
Cuocolo A
, Pace L
*
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
(
637 views
)
(PDF
179 views
)
Medicine (ISSN: 0025-7974)
,
2017 Oct;
96(42): e8344-e8344.
Impact Factor:
2.028
View
Export to BibTeX
Export to EndNote
Marotta V, Di Somma C, Rubino M, Sciammarella C, Modica R,
Camera L
, Del Prete M, Marciello F, Ramundo V, Circelli L, Buonomano P, Colao A, Faggiano A
*
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib
(
424 views
)
Endocrine (ISSN: 1355-008x)
,
2015 Aug;
49(3): 854-858.
Impact Factor:
3.279
View
Export to BibTeX
Export to EndNote
Pace L, Klain M,
Salvatore B
, Nicolai E, Zampella E, Assante R, Pellegrino T,
Storto G
,
Fonti R
,
Salvatore M
*
Prognostic Role of 18F-FDG PET/CT in the Postoperative Evaluation of Differentiated Thyroid Cancer Patients
(
549 views
)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic)
,
2015 Feb;
40(2): 111-115.
Impact Factor:
4.278
View
Export to BibTeX
Export to EndNote
Pace L, Klain M,
Salvatore B
, Nicolai E, Zampella E, Assante R, Pellegrino T,
Storto G
,
Fonti R
,
Salvatore M
*
Prognostic Role Of 18f-Fluorodeoxyglucose Positron Emission Tomography/Ct In The Postoperative Evaluation Of Differentiated Thyroid Cancer Patients
(
373 views
)
Clin Nucl Med (ISSN: 0363-9762, 1536-0229, 1536-0229electronic)
,
2015 Feb;
40(2): 111-115.
Impact Factor:
4.278
View
Export to BibTeX
Export to EndNote
Camera L
, Severino R, Faggiano A, Masone S, Mansueto G,
Maurea S
,
Fonti R
,
Salvatore M
*
Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma
(
758 views
)
World J Radiol (ISSN: 1949-8470, 1949-8470electronic, 1949-8470linking)
,
2014 Oct 28;
6(10): 840-845.
Impact Factor:
0.567
View
Export to BibTeX
Export to EndNote
Perri F, Dell'Oca I, Muto P, Schiavone C, Aversa C, Fulciniti F,
Solla R
, Scarpati GD, Buonerba C, Di Lorenzo G, Caponigro F
*
Optimal management of a patient with recurrent nasopharyngeal carcinoma
(
382 views
)
World Journal Of Clinical Cases (ISSN: 2307-8960)
,
2014;
2(7): 297-300.
Impact Factor:
0.895
View
Export to BibTeX
Export to EndNote
Gallicchio R, Giacomobono S, Capacchione D,
Nardelli A
, Barbato F, Nappi A, Pellegrino T,
Storto G
*
Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?
(
591 views
)
Endocrine (ISSN: 1355-008x, 1355-008xlinking)
,
2013 Oct;
44(2): 426-433.
Impact Factor:
3.527
View
Export to BibTeX
Export to EndNote
Marotta V, Ramundo V,
Camera L
, Del Prete M,
Fonti R
, Esposito R, Palmieri G,
Salvatore M
, Vitale M, Colao A, Faggiano A
*
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: Efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET
(
609 views
)
Clin Endocrinol (ISSN: 0300-0664, 1365-2265, 1365-2265electronic)
,
2013 May;
78(5): 760-767.
Impact Factor:
3.353
View
Export to BibTeX
Export to EndNote
Faggiano A, Ramundo V, Del Prete M, Marotta V, Marciello F,
Camera L
,
Napolitano V
, de LucaL, Lombardi G, Colao A
*
Long-Acting Somatostatin Analogues are Highly Effective in Patients with Early Stage MEN-1-Related Well-Differentiated Neuroendocrine Tumors
(
273 views
)
Neuroendocrinology (ISSN: 0028-3835, 0028-3835linking)
,
2012;
96: N/D-N/D.
Impact Factor:
3.537
View
Export to BibTeX
Export to EndNote
Barbato F, Capacchione D, Nappi A, Telesca D, Tempone A, Casolino E,
Nardelli A
, Castaldi E, Ortosecco G,
Storto G
*
Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131?
(
350 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2010 Oct;
37: N/D-N/D.
Impact Factor:
5.036
View
Export to BibTeX
Export to EndNote
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A,
Del Vecchio S
, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
*
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging
(
657 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2010 Jul;
37(7): 1441-1448.
Impact Factor:
5.036
View
Export to BibTeX
Export to EndNote
Caleo O,
Maurea S
, Klain M,
Salvatore B
,
Storto G
,
Mancini M
, Pace L,
Salvatore M
*
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose
(
365 views
)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic)
,
2009 Dec;
114(8): 1385-1385.
Impact Factor:
1.454
View
Export to BibTeX
Export to EndNote
Pace L, Nicolai E, Klain M,
Salvatore M
*
Diagnostic value of FDG PET/CT imaging
(
549 views
)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking)
,
2009;
53(5): 503-512.
Impact Factor:
1.724
View
Export to BibTeX
Export to EndNote
Salvatore B
, Paone G, Klain M,
Storto G
, Nicolai E, D'Amico D, Della Morte AM, Pace L,
Salvatore M
*
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and 131I ablation
(
791 views
)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking)
,
2008 Mar;
52(1): 2-8.
Impact Factor:
1.724
View
Export to BibTeX
Export to EndNote
Caleo O,
Maurea S
, Klain M,
Salvatore B
,
Storto G
,
Mancini M
, Pace L,
Salvatore M
*
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: Comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose
(
489 views
)
Radiol Med (ISSN: 0033-8362, 1826-6983, 1826-6983electronic)
,
2008 Mar;
113(2): 278-288.
Impact Factor:
0.955
View
Export to BibTeX
Export to EndNote
Storto G
,
Liuzzi R
, Klain M, Albanese C,
Salvatore B
, Pellegrino T,
Cella L
, Soricelli A, Pace L,
Salvatore M
*
Prognostic indicators in patients with differentiated thyroid cancer receiving repeated I-131 therapies
(
408 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2006 Sep;
33: N/D-N/D.
Impact Factor:
4.041
View
Export to BibTeX
Export to EndNote
Pace L, Klain M, Albanese C,
Salvatore B
,
Storto G
, Soricelli A,
Salvatore M
*
Short-term outcome of differentiated thyroid cancer patients receiving a second iodine-131 therapy on the basis of a detectable serum thyroglobulin level after initial treatment
(
507 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2006 Feb;
33(2): 179-183.
Impact Factor:
4.041
View
Export to BibTeX
Export to EndNote
Pace L, Klain M, Soricelli A, Albanese C,
Salvatore B
,
Storto G
,
Salvatore M
*
Short Term Outcome of Differentiated Thyroid Cancer Patients with Detectable Serum Thyroglobulin after Initial Treatment Receiving a Second 131-IODINE Therapy
(
503 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2005 Sep;
32: 179-183.
Impact Factor:
3.883
View
Export to BibTeX
Export to EndNote
Tauchmanovà L, Pensabene M, Capuano I, Spagnoletti I, Zeppa P,
Del Vecchio S
,
Mainenti PP
, De Rosa G, Colao A, Contegiacomo A
*
Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: Response to chemotherapy and octreotide LAR
(
490 views
)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic)
,
2005 Apr;
28(4): 371-378.
Impact Factor:
1.496
View
Export to BibTeX
Export to EndNote
Klain M,
Storto G
, Capacchione D, Paone G, Pellegrino T, Nicolai E, Della Morte A, D'Amico D, Soricelli A, Pace L,
Salvatore M
*
18-F-FDG PET evaluation of patients with differentiated thyroid tumors
(
355 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2004 Sep;
31: N/D-N/D.
Impact Factor:
3.935
View
Export to BibTeX
Export to EndNote
Storto G
, Klain M, Bracigliano A, Paone G, Capacchione D, Albanese C, Pace L, Soricelli A,
Salvatore M
*
I-131 therapy of differentiated thyroid tumors less than 1 cm: comparison between two different therapeutic regimens
(
430 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2004 Sep;
31: N/D-N/D.
Impact Factor:
3.935
View
Export to BibTeX
Export to EndNote
Klain M, Pellegrino T,
Storto G
, Biondi B, Sansone V, Pagano L, Nicolai E, Della Morte A, D'Amico D, Soricelli A, Lombardi G, Pace L,
Salvatore M
*
Postsurgical follow up of differentiated thyroid cancer using rhTSH
(
364 views
)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997)
,
2004 Sep;
31: N/D-N/D.
Impact Factor:
3.935
View
Export to BibTeX
Export to EndNote
Biondi B, Palmieri EA, Pagano L, Klain M, Scherillo G,
Salvatore M
, Fenzi G, Lombardi G, Fazio S
*
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer
(
517 views
)
J Clin Endocrinol Metab (ISSN: 0021-972x)
,
2003 Jan;
88(1): 211-214.
Impact Factor:
5.873
View
Export to BibTeX
Export to EndNote
Klain M,
Maurea S
, Lastoria S,
Cuocolo A
, Colao A,
Salvatore M
Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer
(
431 views
)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic)
,
1995 Dec;
36(12): 2248-2251.
Impact Factor:
3.491
View
Export to BibTeX
Export to EndNote
26
Records (
19
excluding Abstracts).
Total impact factor:
81.993
(
56.12
excluding Abstracts).
Total 5 year impact factor:
78.665
(
49.99
excluding Abstracts).
Top of page
Copy&Paste Friendly
Export all to BibTeX
Export all to EndNote
Last modified by
Marco Comerci
on Sunday 12 July 2020, 13:14:53
335 views.
Last view on Tuesday 10 December 2024, 8:45:02